ABBV-428 is an Immuno-Oncology therapy under development for the treatment of solid tumors.

Type of Molecule

Biologic

Target

n/a

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Solid Tumors New Indication Phase 1